CeriBell Inc
CBLL11.570USD
+0.130+1.14%
Horarios del mercado （ET）Cotizaciones retrasadas 15 min
423.46MCap. mercado
PérdidaP/E TTM
Más Datos de CeriBell Inc Compañía
Ceribell, Inc. is a commercial-stage medical technology company. It is focused on transforming the diagnosis and management of patients with serious neurological conditions. It has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, highly portable and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Point-of-Care EEG enables early detection and management of suspected seizure patients, promoting precise patient care and hospital-wide efficiencies. Its Clarity AI algorithm interprets EEG in real-time, provides bedside alerts and continuous monitoring for status epilepticus. The Ceribell EEG Portal makes it easy to remotely review EEG in real-time with pre-annotated EEG insights.
Información de la empresa
Símbolo de cotizaciónCBLL
Nombre de la empresaCeribell Inc
Fecha de salida a bolsaOct 11, 2024
Director ejecutivoMs. Xingjuan (Jane) Chao, Ph.D.
Número de empleados281
Tipo de seguridadOrdinary Share
Fin del año fiscalOct 11
Dirección360 N. Pastoria Avenue
CiudadSUNNYVALE
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal94085
Teléfono18004360826
Sitio Webhttps://ceribell.com/
Símbolo de cotizaciónCBLL
Fecha de salida a bolsaOct 11, 2024
Director ejecutivoMs. Xingjuan (Jane) Chao, Ph.D.
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Josef Parvizi, M.D., Ph.D.
Dr. Josef Parvizi, M.D., Ph.D.
Director, Co-Founder
Director, Co-Founder
2.09M
+0.32%
Ms. Xingjuan (Jane) Chao, Ph.D.
Ms. Xingjuan (Jane) Chao, Ph.D.
President, Chief Executive Officer, Director, Co-Founder
President, Chief Executive Officer, Director, Co-Founder
1.05M
-0.27%
Dr. Raymond Woo, Ph.D.
Dr. Raymond Woo, Ph.D.
Chief Technology Officer
Chief Technology Officer
484.18K
+4.31%
Mr. Scott Blumberg
Mr. Scott Blumberg
Chief Financial Officer
Chief Financial Officer
88.68K
-0.77%
Mr. Joseph M. Taylor
Mr. Joseph M. Taylor
Independent Director
Independent Director
52.06K
-41.11%
Mr. William W. (Bill) Burke
Mr. William W. (Bill) Burke
Independent Director
Independent Director
17.39K
+103.09%
Brian Johnston
Brian Johnston
Investor Relations
Investor Relations
--
--
Joseph Manni
Joseph Manni
Chief Revenue Officer
Chief Revenue Officer
--
--
Ms. Rebecca B. (Beckie) Robertson
Ms. Rebecca B. (Beckie) Robertson
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Lucian Iancovici, M.D.
Dr. Lucian Iancovici, M.D.
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Josef Parvizi, M.D., Ph.D.
Dr. Josef Parvizi, M.D., Ph.D.
Director, Co-Founder
Director, Co-Founder
2.09M
+0.32%
Ms. Xingjuan (Jane) Chao, Ph.D.
Ms. Xingjuan (Jane) Chao, Ph.D.
President, Chief Executive Officer, Director, Co-Founder
President, Chief Executive Officer, Director, Co-Founder
1.05M
-0.27%
Dr. Raymond Woo, Ph.D.
Dr. Raymond Woo, Ph.D.
Chief Technology Officer
Chief Technology Officer
484.18K
+4.31%
Mr. Scott Blumberg
Mr. Scott Blumberg
Chief Financial Officer
Chief Financial Officer
88.68K
-0.77%
Mr. Joseph M. Taylor
Mr. Joseph M. Taylor
Independent Director
Independent Director
52.06K
-41.11%
Mr. William W. (Bill) Burke
Mr. William W. (Bill) Burke
Independent Director
Independent Director
17.39K
+103.09%
Desglose de ingresos
Divisa: USDActualizado: dom., 6 de jul
Divisa: USDActualizado: dom., 6 de jul
FY2025Q1
FY2024
FY2023
FY2022
Por negocioUSD
Nombre
Ganancia
Proporción
EEG recorders and EEG headbands, point in time
15.61M
76.17%
EEG portal and Clarity subscriptions, over time
4.88M
23.83%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
20.49M
100.00%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
EEG recorders and EEG headbands, point in time
15.61M
76.17%
EEG portal and Clarity subscriptions, over time
4.88M
23.83%
Estadísticas de accionistas
Actualizado: lun., 8 de sep
Actualizado: lun., 8 de sep
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Fidelity Management & Research Company LLC
12.79%
TPG Capital, L.P.
10.82%
Longitude Capital Management Co., LLC
6.75%
Ally Bridge Group (HK) Limited
6.66%
Global Value Investment Portfolio Management Pte. Ltd.
6.46%
Otro
56.52%
Accionistas
Accionistas
Proporción
Fidelity Management & Research Company LLC
12.79%
TPG Capital, L.P.
10.82%
Longitude Capital Management Co., LLC
6.75%
Ally Bridge Group (HK) Limited
6.66%
Global Value Investment Portfolio Management Pte. Ltd.
6.46%
Otro
56.52%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
41.33%
Investment Advisor/Hedge Fund
18.68%
Private Equity
10.82%
Individual Investor
10.46%
Venture Capital
9.21%
Hedge Fund
2.82%
Research Firm
0.96%
Pension Fund
0.28%
Bank and Trust
0.19%
Otro
5.26%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
162
33.13M
90.36%
+3.75M
2025Q1
157
34.07M
94.45%
+6.99M
2024Q4
111
32.79M
91.42%
+9.94M
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Fidelity Management & Research Company LLC
4.75M
13.15%
-38.89K
-0.81%
Mar 31, 2025
TPG Capital, L.P.
3.97M
10.98%
--
--
Mar 31, 2025
Longitude Capital Management Co., LLC
2.48M
6.85%
+2.48M
--
Oct 16, 2024
Ally Bridge Group (HK) Limited
2.18M
6.02%
-134.10K
-5.80%
Apr 11, 2025
Global Value Investment Portfolio Management Pte. Ltd.
2.37M
6.55%
--
--
Dec 31, 2024
Red Tree Management, LLC
2.21M
6.1%
--
--
Mar 31, 2025
Parvizi (Josef)
2.09M
5.78%
+6.62K
+0.32%
Apr 11, 2025
BlackRock Institutional Trust Company, N.A.
782.72K
2.17%
+78.31K
+11.12%
Mar 31, 2025
The Vanguard Group, Inc.
693.83K
1.92%
-2.26K
-0.32%
Mar 31, 2025
Chao (Xingjuan)
1.05M
2.92%
--
--
Jun 03, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 6 de sep
Actualizado: sáb., 6 de sep
Nombre
Proporción
iShares Neuroscience and Healthcare ETF
0.55%
Hypatia Women CEO ETF
0.45%
ProShares Hedge Replication ETF
0.01%
ProShares UltraPro Russell2000
0.01%
Franklin US Small Cap Multifactor Index ETF
0%
FlexShares Morningstar US Market Factor Tilt Index Fund
0%
iShares Morningstar Small-Cap ETF
0%
iShares Russell 2000 Value ETF
0%
iShares Neuroscience and Healthcare ETF
Proporción0.55%
Hypatia Women CEO ETF
Proporción0.45%
ProShares Hedge Replication ETF
Proporción0.01%
ProShares UltraPro Russell2000
Proporción0.01%
Franklin US Small Cap Multifactor Index ETF
Proporción0%
FlexShares Morningstar US Market Factor Tilt Index Fund
Proporción0%
iShares Morningstar Small-Cap ETF
Proporción0%
iShares Russell 2000 Value ETF
Proporción0%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
